These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 28746208)

  • 1. Myopathy in hyperthyroidism as a consequence of rapid reduction of thyroid hormone: A case report.
    Li Q; Liu Y; Zhang Q; Tian H; Li J; Li S
    Medicine (Baltimore); 2017 Jul; 96(30):e7591. PubMed ID: 28746208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myopathy after rapid correction of hyperthyroidism: A case report and review of literature.
    Lu R; Wang H; Hong T; Gao H
    Medicine (Baltimore); 2020 Jan; 99(3):e18878. PubMed ID: 32011514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevation of serum creatine kinase during treatment with antithyroid drugs in patients with hyperthyroidism due to Graves disease. A novel side effect of antithyroid drugs.
    Suzuki S; Ichikawa K; Nagai M; Mikoshiba M; Mori J; Kaneko A; Sekine R; Asanuma N; Hara M; Nishii Y; Yamauchi K; Aizawa T; Hashizume K
    Arch Intern Med; 1997 Mar; 157(6):693-6. PubMed ID: 9080924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of thyrotoxic myopathy with generalized body muscular atrophy including the tongue muscle, lacking physical manifestations of Basedow disease].
    Kitahara S; Tonouchi T; Otsu Y; Kawachi I; Oyake M; Fujita N
    Rinsho Shinkeigaku; 2020 Oct; 60(10):677-681. PubMed ID: 32893239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Long-Term Outcome of Treatment for Graves' Hyperthyroidism.
    Sjölin G; Holmberg M; Törring O; Byström K; Khamisi S; de Laval D; Abraham-Nordling M; Calissendorff J; Lantz M; Hallengren B; Filipsson Nyström H; Wallin G
    Thyroid; 2019 Nov; 29(11):1545-1557. PubMed ID: 31482765
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparison of the effectiveness of 131-I and antithyroid drugs in the treatment of Graves' disease in children].
    Chen DY; Chen TH
    Zhonghua Er Ke Za Zhi; 2005 Jul; 43(7):507-9. PubMed ID: 16083551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory tests for evaluating thyroid therapy.
    Kabadi UM
    Am Fam Physician; 1982 Sep; 26(3):183-8. PubMed ID: 6180620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myopathy Associated with Treatment of Graves' Disease.
    Ji YK; Kim SH
    Medicina (Kaunas); 2021 Sep; 57(10):. PubMed ID: 34684053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and treatment of Graves disease.
    Streetman DD; Khanderia U
    Ann Pharmacother; 2003; 37(7-8):1100-9. PubMed ID: 12841824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Graves' Disease: Can It Be Cured?
    Wiersinga WM
    Endocrinol Metab (Seoul); 2019 Mar; 34(1):29-38. PubMed ID: 30912336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-ablative hypothyroidism.
    Yaqub A; Choudhry MI; Wheaton J; Gress T
    W V Med J; 2011; 107(2):37-40. PubMed ID: 21476476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of hypothyroidism with thyroid stimulation blocking antibody long after treatment with antithyroid drugs in a patient with hyperthyroid Graves' disease: a case report.
    Kasuga Y; Sugenoya A; Kobayashi S; Shimizu T; Onuma H; Shingu K; Asanuma K; Hama Y; Iida F
    Endocr J; 1993 Apr; 40(2):227-30. PubMed ID: 7524926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of Graves' disease--antithyroid drug therapy].
    Onaya T
    Nihon Rinsho; 1999 Aug; 57(8):1846-50. PubMed ID: 10483263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacodynamic Response to Anti-thyroid Drugs in Graves' Hyperthyroidism.
    Abbara A; Clarke SA; Brewster R; Simonnard A; Eng PC; Phylactou M; Papadopoulou D; Izzi-Engbeaya C; Sam AH; Wernig F; Jonauskyte E; Comninos AN; Meeran K; Kelsey TW; Dhillo WS
    Front Endocrinol (Lausanne); 2020; 11():286. PubMed ID: 32477269
    [No Abstract]   [Full Text] [Related]  

  • 15. Cross-sectional investigation of serum creatine kinase concentration in Graves disease patients treated with oral antithyroid drugs.
    Cheng Y; Sun Z; Zhong D; Ren L; Yang H
    Medicine (Baltimore); 2020 Oct; 99(43):e22898. PubMed ID: 33120839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selenium supplementation for patients with Graves' hyperthyroidism (the GRASS trial): study protocol for a randomized controlled trial.
    Watt T; Cramon P; Bjorner JB; Bonnema SJ; Feldt-Rasmussen U; Gluud C; Gram J; Hansen JL; Hegedüs L; Knudsen N; Bach-Mortensen P; Nolsøe R; Nygaard B; Pociot F; Skoog M; Winkel P; Rasmussen AK
    Trials; 2013 Apr; 14():119. PubMed ID: 23782950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PREDICTION OF RELAPSE FROM HYPERTHYROIDISM FOLLOWING ANTITHYROID MEDICATION WITHDRAWAL USING TECHNETIUM THYROID UPTAKE SCANNING.
    Nakhjavani M; Abdollahi S; Farzanefar S; Abousaidi M; Esteghamati A; Naseri M; Eftekhari M; Abbasi M
    Endocr Pract; 2017 Apr; 23(4):466-470. PubMed ID: 28437154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves' hyperthyroidism.
    Roti E; Gardini E; Minelli R; Bianconi L; Salvi M; Gavaruzzi G; Braverman LE
    J Clin Endocrinol Metab; 1993 Apr; 76(4):928-32. PubMed ID: 7682562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative change of thyroid stimulating hormone receptor antibody level: possible marker for predicting recurrent hyperthyroidism in patients with Graves' disease after subtotal thyroidectomy.
    Sugino K; Mimura T; Ozaki O; Iwasaki H; Wada N; Matsumoto A; Ito K
    World J Surg; 1996 Sep; 20(7):801-6; discussion 806-7. PubMed ID: 8678954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abrupt onset of muscle dysfunction after treatment for Grave's disease: a case report.
    Hernán Martínez J; Sánchez A; Torres O; Palermo C; Santiago M; Figueroa C; Trinidad R; Mangual M; Gutierrez M; González E; Miranda Mde L
    Bol Asoc Med P R; 2014; 106(1):40-2. PubMed ID: 24791363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.